Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.52 (
PNGase F
)
1,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intercellular adhesion molecule (ICAM)-2 is highly expressed on platelets and endothelium and is a counter-receptor for the leukocyte integrin, lymphocyte function-associated antigen-1 (LFA-1) and for the dendritic cell-specific, ICAM-grabbing non-integrin (DC-SIGN) protein. In this study, we investigated structural and functional differences between
ICAM-2
from platelets and that from endothelial cells. The isoelectric point (pI) of
ICAM-2
from HUVEC was pH 3.5-4.3, whereas that of platelet
ICAM-2
was more acidic at pH 3.0-3.7. This charge difference was abolished by treatment with
N-glycanase
or neuraminidase, thus it was due to cell-specific N-linked glycosylation. Purified, immobilized platelet
ICAM-2
supported 50% less adhesion of LFA-1-bearing T cells than did purified HUVEC
ICAM-2
and no adhesion was observed of monocyte-derived immature dendritic cells via DC-SIGN to platelet
ICAM-2
. Treatment of platelet
ICAM-2
with neuraminidase abolished these functional differences. These findings demonstrated that physiologic sialylation of platelet
ICAM-2
renders it less able than endothelial
ICAM-2
to support adherence of leukocytes.
...
PMID:Sialylation of ICAM-2 on platelets impairs adhesion of leukocytes via LFA-1 and DC-SIGN. 1567 59